These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 12149047

  • 1. Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus.
    Wagstaff AJ, Goa KL.
    Drugs; 2002; 62(12):1805-37. PubMed ID: 12149047
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Troglitazone: a review of its use in the management of type 2 diabetes mellitus.
    Plosker GL, Faulds D.
    Drugs; 1999 Mar; 57(3):409-38. PubMed ID: 10193691
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Repaglinide: a review of its therapeutic use in type 2 diabetes mellitus.
    Culy CR, Jarvis B.
    Drugs; 2001 Mar; 61(11):1625-60. PubMed ID: 11577798
    [Abstract] [Full Text] [Related]

  • 8. A review of rosiglitazone in type 2 diabetes mellitus.
    Werner AL, Travaglini MT.
    Pharmacotherapy; 2001 Sep; 21(9):1082-99. PubMed ID: 11560198
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rosiglitazone : a review of its use in type 2 diabetes mellitus.
    Deeks ED, Keam SJ.
    Drugs; 2007 Sep; 67(18):2747-79. PubMed ID: 18062722
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Rosiglitazone.
    Goldstein BJ.
    Int J Clin Pract; 2000 Jun; 54(5):333-7. PubMed ID: 10954962
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes.
    Iozzo P, Hallsten K, Oikonen V, Virtanen KA, Parkkola R, Kemppainen J, Solin O, Lonnqvist F, Ferrannini E, Knuuti J, Nuutila P.
    Diabetes Care; 2003 Jul; 26(7):2069-74. PubMed ID: 12832315
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Rosiglitazone.
    Balfour JA, Plosker GL.
    Drugs; 1999 Jun; 57(6):921-30; discussion 931-2. PubMed ID: 10400405
    [Abstract] [Full Text] [Related]

  • 17. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ, Bailey CJ.
    Drugs; 2005 Jun; 65(3):385-411. PubMed ID: 15669880
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Promising new approaches.
    Reasner CA.
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [Abstract] [Full Text] [Related]

  • 20. Rosiglitazone and pioglitazone: new preparations. Two new oral antidiabetics both poorly assessed.
    Prescrire Int; 2002 Dec; 11(62):170-6. PubMed ID: 12469695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.